A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Ambulatory Care Facilities Reshape FM Strategies
Intermountain Foundation Receives $150M Gift for Children's Hospital in Nevada
Texas HHSC Reaches Construction Milestone for Wichita Falls State Hospital
Preparing Healthcare Facilities for Wildfire Air Quality Events
UW Health Set to Open Expansion at East Madison Hospital